Other authors pointed out that the rare presence of GLP-1R-positive medullary thyroid carcinoma might be a candidate for in vivo scintigraphy and targeted radiotherapy [18]. The gene discussed is GLP1R; the disease is medullary thyroid gland carcinoma.